Patients with pollen-related allergic rhinitis prefer on demand antihistamines, with treatment preferences differing markedly ...
The perennial allergic rhinitis market is projected to progress steadily, supported by a relatively small but focused pipeline of emerging therapies. Companies developing candidates such as EBGLYSS ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with chronic rhinitis who had ...
Neurent Medical today announced positive findings from a randomized controlled trial evaluating its Neuromark system.
GALWAY, Ireland--(BUSINESS WIRE)--Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced three-month data from ...
An update of recommendations for the treatment of seasonal allergic rhinitis (SAR) in adolescents and adults, issued by members of the Joint Task Force on Practice Parameters (JTFPP), changes initial ...
The Cigna Group CI recently announced that it will start covering RhinAer, a minimally invasive solution for chronic rhinitis, starting Sept. 15, 2025. This move highlights the increasing confidence ...
Neurent Medical Closes $25 Million Series B Funding to Advance Innovative Chronic Rhinitis Treatment
GALWAY, Ireland--(BUSINESS WIRE)--Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced it has closed a $25 million Series B ...
Nuvo obtains Health Canada approval to conduct WF10 Phase 2 trial for treatment of allergic rhinitis
Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced it has received Health Canada approval to conduct a new ...
The "Allergic Rhinitis Market- A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The global ...
(MENAFN- GlobeNewsWire - Nasdaq) The perennial allergic rhinitis market is projected to progress steadily, supported by a relatively small but focused pipeline of emerging therapies. Companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results